Simon O’Connor

659 total citations
23 papers, 379 citations indexed

About

Simon O’Connor is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Simon O’Connor has authored 23 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 5 papers in Oncology. Recurrent topics in Simon O’Connor's work include Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Simon O’Connor is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Simon O’Connor collaborates with scholars based in United Kingdom, United States and Netherlands. Simon O’Connor's co-authors include Stephen Chua, Faizatul Izza Rozalli, Alistair Robson, I Lauder, Christopher McNamara, David M. Clark, Andrew McMillan, Andrew Haynes, Rakesh Ganatra and Chee Leong Cheng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Simon O’Connor

21 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon O’Connor United Kingdom 11 224 125 97 74 69 23 379
Jadwiga Małdyk Poland 12 267 1.2× 108 0.9× 102 1.1× 87 1.2× 61 0.9× 33 463
Greg Hapgood Australia 9 226 1.0× 123 1.0× 73 0.8× 55 0.7× 50 0.7× 28 390
Pamela B. Allen United States 11 303 1.4× 229 1.8× 101 1.0× 112 1.5× 76 1.1× 56 461
Tariq Muzzafar United States 14 220 1.0× 152 1.2× 84 0.9× 79 1.1× 48 0.7× 34 507
Thamathorn Assanasen Thailand 8 441 2.0× 248 2.0× 152 1.6× 146 2.0× 75 1.1× 16 550
Sheng‐Tsung Chang Taiwan 14 356 1.6× 301 2.4× 44 0.5× 121 1.6× 35 0.5× 38 495
Francesca Montanari Italy 12 215 1.0× 217 1.7× 34 0.4× 77 1.0× 41 0.6× 57 407
Tommasina Perrone Italy 14 245 1.1× 183 1.5× 31 0.3× 154 2.1× 57 0.8× 41 562
Lister Germany 3 233 1.0× 139 1.1× 54 0.6× 35 0.5× 27 0.4× 4 323
Mariko Yabe United States 14 199 0.9× 142 1.1× 62 0.6× 113 1.5× 29 0.4× 39 466

Countries citing papers authored by Simon O’Connor

Since Specialization
Citations

This map shows the geographic impact of Simon O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon O’Connor more than expected).

Fields of papers citing papers by Simon O’Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon O’Connor. The network helps show where Simon O’Connor may publish in the future.

Co-authorship network of co-authors of Simon O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Simon O’Connor. A scholar is included among the top collaborators of Simon O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon O’Connor. Simon O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Bhupinder, Vasiliki Michalarea, Mary Gleeson, et al.. (2023). Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital. Clinical Lymphoma Myeloma & Leukemia. 24(1). 48–54.
2.
Vroobel, Katherine, Simon O’Connor, David Cunningham, et al.. (2019). Florid T follicular helper cell hyperplasia associated with extranodal marginal zone lymphoma: a diagnostic pitfall which may mimic T cell lymphoma. Histopathology. 75(2). 287–290. 6 indexed citations
3.
Litchfield, Kevin, Max Levy, Darshna Dudakia, et al.. (2016). Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility. Nature Communications. 7(1). 13840–13840. 29 indexed citations
4.
Munir, Talha, Mark Bishton, Ian Carter, et al.. (2016). Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate. Clinical Lymphoma Myeloma & Leukemia. 16(12). 705–712. 3 indexed citations
5.
Cheng, Chee Leong & Simon O’Connor. (2016). T cell-rich lymphoid infiltrates with large B cells: a review of key entities and diagnostic approach. Journal of Clinical Pathology. 70(3). 187–201. 11 indexed citations
6.
Taibjee, Saleem, Simon O’Connor, Mojca Persic, et al.. (2015). Indolent CD8‐positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. Journal of Cutaneous Pathology. 43(2). 125–136. 31 indexed citations
7.
8.
Alomar, Thaer, Khalid Mahmood, Simon O’Connor, Keith Robson, & Harminder S. Dua. (2013). Localized conjunctival extra-nodal marginal zone B cell lymphoma with presumed paraproteinic crystalline keratopathy. International Ophthalmology. 33(5). 561–565.
9.
Bessell, E.M., et al.. (2012). Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification. British Journal of Dermatology. 167(5). 1118–1123. 17 indexed citations
10.
Dickinson, P., et al.. (2011). Primary cutaneous marginal zone B cell lymphoma in monozygotic twins. BMJ Case Reports. 2011. bcr1120103515–bcr1120103515. 2 indexed citations
11.
Fox, Christopher P., Tracey A. Haigh, Graham S. Taylor, et al.. (2010). A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy. Blood. 116(19). 3695–3704. 63 indexed citations
12.
13.
Chua, Stephen, Faizatul Izza Rozalli, & Simon O’Connor. (2008). Imaging features of primary extranodal lymphomas. Clinical Radiology. 64(6). 574–588. 47 indexed citations
14.
Chua, Stephen, et al.. (2008). Solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature. British Journal of Radiology. 81(964). e110–e114. 25 indexed citations
15.
Lyall, Hamish, Simon O’Connor, & David M. Clark. (2007). Charcot‐Leyden crystals in the trephine biopsy of a patient with a FIP1L1‐PDGFRA– positive myeloproliferative disorder. British Journal of Haematology. 138(4). 405–405. 4 indexed citations
16.
Birchall, J. D., et al.. (2007). The value of 99mTc-MDP bone scintigraphy in staging primary lymphoma of bone. Nuclear Medicine Communications. 28(7). 529–531. 3 indexed citations
17.
O’Connor, Simon, et al.. (2002). Angiotropic lymphoma occurring in a lacrimal sac oncocytoma. Journal of Clinical Pathology. 55(10). 787–788. 14 indexed citations
18.
O’Connor, Simon, Peter B. Farmer, & I Lauder. (1999). Benzene and non‐Hodgkin's lymphoma. The Journal of Pathology. 189(4). 448–453. 1 indexed citations
19.
O’Connor, Simon, et al.. (1999). Benzene and non-Hodgkin's lymphoma. The Journal of Pathology. 189(4). 448–453. 36 indexed citations
20.
Nacheva, E, Martin J.S. Dyer, D Jadayel, et al.. (1994). B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression. Blood. 84(10). 3422–3428. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jadwiga Małdyk Breakdown of academic impact, for papers by Greg Hapgood Breakdown of academic impact, for papers by Pamela B. Allen Breakdown of academic impact, for papers by Tariq Muzzafar Breakdown of academic impact, for papers by Thamathorn Assanasen Breakdown of academic impact, for papers by Sheng‐Tsung Chang Breakdown of academic impact, for papers by Francesca Montanari Breakdown of academic impact, for papers by Tommasina Perrone Breakdown of academic impact, for papers by Lister Breakdown of academic impact, for papers by Mariko Yabe
Rankless by CCL
2026